Login

Dror Bashan, CEO, Protalix Biotherapeutics Inc 00:00:00

Share On Facebook Share On Twitter

Protalix BioTherapeutics looks to commercialize its Fabry Disease therapy

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:00:00
Viktor Drvota Chief Executive Officer, Karolinska Development
00:10:00
Gold and Silver Market Insights and Outlook for 2023
00:10:00
Unlocking ArcMail's Speed: Next-Gen Interface Demo for Hosted Customers | Brett Jackson, CEO, Cyren LtdCYRN:NAQ
00:10:00
Mastering Market Dynamics: Insights from Gabriel Shahin - Gabriel Shahin | CFP® and President | Falcon Wealth Planning, Inc.
00:10:00
Market Correction: Navigating Volatility and Diversification
00:10:00
Swedish Company Explores and Develops Gold Deposits in Siberia's Lena Gold Fields, Russia
00:10:00
Nasdaq Interview Harness The Power of AI with Chad Steelberg | Chad Steelberg, CEO, Veritone IncVERI:NMQ
00:10:00
Therese Tucker of BlackLine Talks About the Intersection of Accounting and Technology | Therese Tucker, CEO, BlackLine Inc.
00:10:00
Veritas Capital Acquires Northrop Grumman's Services Unit for $3.4 Billion
00:10:00
Relocating After Retirement: 3 Key Considerations | Ron Bernstein, Co-founder , Prism Planning Partners.
00:10:00
Jindalee Completes Share Allocation and Updates on McDermitt Lithium Drilling Progress
00:10:00
Megatrends: Forecasting AI’s Impact on Our Jobs with Vanguard’s Joe Davis, Ph.D.

© 2017 - Neuhu+